With these core differences established, the next step is determining which option suits your specific health situation
3.2 Primary outcome Statistical results showed that mean SD of the primary outcome Scr after treatment were 207.3 63.4, 177.4 54.6 in RG group and RG + CHF group respectively
There is also some evidence that these drugs can alter the gut microbiome (the community of bacteria in your intestines), which might have subtle effects on nutrient metabolism
Ozempic and Wegovy both come in easy-to-use prefilled injection pens, so you can be sure youre injecting yourself with the correct amount every time

There was an average 74-fold increase in adaptor related protein complex 5 subunit zeta 1 (AP5Z1) (log2 fold = 6.201, P = 0.005), 53 fold increase in VPS8 subunit of CORVET complex (VPS8) (log2 fold = 5.730, P = 0.043), 19 fold increase in integrator complex subunit 6 INTS6 (log2 fold = 4.234, P = 0.041), 18 fold increase in calumenin (CALU) (log2 fold = 4.135, P = 0.012), 16 fold increase in insulin-like growth factor binding protein 5 (IGFBP5) (log2 fold = 4.008, P = 0.015), tenfold increase in RNA polymerase mitochondrial (POLRMT) (log2 fold = 3.355, P = 0.020), sevenfold increase in KIT proto-oncogene receptor tyrosine kinase (KIT) (log2 fold = 2.891, P = 0.033), sevenfold increase in ciliary rootlet coiled-coil, rootletin (CROCC) (log2 fold = 2.742, P = 0.043), sixfold increase in polymeric immunoglobulin receptor (PIGR) (log2 fold = 2.684, P = 0.041) GP levels at the end of 4th week during 4-week intermittent fasting compared with the levels before 4-week intermittent fasting

Interestingly, metabolomic analysis in this study indicated that semaglutide treatment upregulated L-isoleucine and methacholine or downregulated L-histidinol, arachidonic acid, and 4,5- leukotriene (LT) A4 LysoPC(16:0), which are metabolites involved in the pathogenesis of NAFLD [32]